We are conducting research and development with the aim of creating new medicines useful in treating patients. Our core pharmaceutical business focuses resources on the targeted areas of cardiovascular medicine, obstetrics and gynecology, psychiatry and gastroenterology. Additionally, we provide medicines for intractable disease as well as generics including biosimilars, to meet medical needs.